GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DocGo Inc (NAS:DCGO) » Definitions » Cash Conversion Cycle

DocGo (DCGO) Cash Conversion Cycle : 112.88 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is DocGo Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

DocGo's Days Sales Outstanding for the three months ended in Mar. 2024 was 129.5.
DocGo's Days Inventory for the three months ended in Mar. 2024 was 0.
DocGo's Days Payable for the three months ended in Mar. 2024 was 16.62.
Therefore, DocGo's Cash Conversion Cycle (CCC) for the three months ended in Mar. 2024 was 112.88.


DocGo Cash Conversion Cycle Historical Data

The historical data trend for DocGo's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DocGo Cash Conversion Cycle Chart

DocGo Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Cash Conversion Cycle
66.94 53.66 41.84 51.25 89.10

DocGo Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 71.91 76.90 74.26 97.59 112.88

Competitive Comparison of DocGo's Cash Conversion Cycle

For the Medical Care Facilities subindustry, DocGo's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DocGo's Cash Conversion Cycle Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DocGo's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where DocGo's Cash Conversion Cycle falls into.



DocGo Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

DocGo's Cash Conversion Cycle for the fiscal year that ended in Dec. 2023 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=106.72+0-17.62
=89.10

DocGo's Cash Conversion Cycle for the quarter that ended in Mar. 2024 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=129.5+0-16.62
=112.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DocGo  (NAS:DCGO) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


DocGo Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of DocGo's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


DocGo (DCGO) Business Description

Traded in Other Exchanges
N/A
Address
35 West 35th Street, Floor 6, New York, NY, USA, 10001
DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. DocGo is disrupting the traditional four-wall healthcare system by providing care at the scale of humanity. Its technology and dedicated field staff of certified health professionals elevate the quality of patient care and drive business efficiencies for facilities, hospital networks, and health insurance providers. With Mobile Health, DocGo empowers the full promise and potential of telehealth by facilitating healthcare treatment, in tandem with a remote physician, in the comfort of a patient's home or workplace.
Executives
Stephen Sugrue officer: Chief Compliance Officer 35 WEST 35TH STREET, FLOOR 6, NEW YORK NY 10001
Lee Bienstock officer: Chief Operating Officer 35 WEST 35TH STREET, FLOOR 6, NEW YORK NY 10001
Ely D Tendler director, officer: General Counsel, Secretary STRATEGIC AND LEGAL SERVICES, PLLC, 54 LAWRENCE AVENUE, LAWRENCE NY 11559
Anthony Capone officer: President 106 DUANE ST., #3, NEW YORK NY 10007
Adriaan Stephanus Oberholzer officer: Chief Financial Officer 35 W 35TH STREET, 6TH FLOOR, NEW YORK NY 10001
James M Travers director C/O FLEETMATICS, 1100 WINTER STREET, 4TH FL, WALTHAM MA 02451
Etalvina Leite director 5477 VIA NICOLA, NEWBURY PARK CA 91320
Michael J Burdiek director 39 PARKER, IRVINE CA 92618
Ira Smedra director 401 N. JUNE STREET, LOS ANGELES CA 90004
Mark Do Merlin officer: CMO, Ambulnz Holdings, LLC 35 W 35TH STREET, NEW YORK NY 10001
Michael S. Witkowski officer: Chief Compliance Officer PO BOX 10482, NEWBURGH NY 12552
Christopher Fillo director 3110 MAIN STREET, SUITE 310, SANTA MONICA CA 90405
Norman Rosenberg officer: CFO, Ambulnz Holdings, LLC 51 MOUNTAIN AVENUE, MONSEY NY 10952
Stanley Vashovsky director, 10 percent owner, officer: Chief Executive Officer 763 RALEIGH STREET, WOODMERE NY 11598
Steven Katz director 20 REBEL RUN DR, EAST BRUNSWICK NJ 08816